Access

Correspondence

Nature 440, 278 (16 March 2006) | doi:10.1038/440278b; Published online 15 March 2006

Open Innovation Challenges

  • Optimizing Sub-cellular Localization Tags

    • Deadline: Jan 31 2010
    • Reward: $20,000 USD

    The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....

  • Single-cell Analysis Platform

    • Deadline: Dec 02 2009
    • Reward: $5,000 USD

    This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...

naturejobs

Lyme vaccine demonized by advocacy groups

Edward McSweegan1

  1. 1692 Barrister Court, Crofton, Maryland 21114, USA

As a microbiologist who managed a federal programme on Lyme disease in the 1990s, I consider that any new clinical trials of a vaccine candidate based on the protein OspA, as mentioned in your News Feature "Uphill struggle" (Nature 439, 524–525; 2006), should be confined to Europe, for three reasons.First, Lyme disease is non-communicable, readily treatable with common antibiotics and geographically localized in the United States.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.